查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1319085

女性健康市场：按年龄（13-17、18-35、36+）、分销管道（医院、线上、零售）、按用途- 2023-2030 年全球预测

Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球女性健康市场预计将大幅成长，到 2023 年将达到 432.3 亿美元，年复合成长率为 8.91%，预计到 2030 年将达到惊人的 789 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球女性健康市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球女性健康市场规模及预测为何？

2. 在预测期内，COVID-19 对全球女性健康市场的阻碍因素与影响有哪些？

3. 在预测期内，全球女性健康市场需要投资哪些产品/细分市场/应用/领域？

4. 你们在全球女性健康市场的竞争策略是什么？

5. 全球女性健康市场的技术趋势和法律规范是什么？

6. 全球女性健康市场主要供应商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球女性健康市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 女性荷尔蒙失衡和慢性疾病增加
      • 超级食品的流行趋势和女性复合维生素供应的增加
      • 女性对天然和植物性保健补充食品的趋势
    • 抑制因素
      • 临床治疗费用高
    • 机会
      • 活性化旨在开发荷尔蒙失调治疗药物的研发活动
      • 世界各国政府为改善妇女健康所推出的有利政策
    • 任务
      • 与药物摄取相关的副作用
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章依年龄分類的女性健康市场

  • 13-17岁
  • 18-35岁
  • 36岁以上

第7章女性保健品市场：依通路划分

  • 医院
  • 在线的
  • 零售

第8章女性健康市场：依用途

  • 避孕药
  • 子宫内膜异位症和子宫肌瘤
  • 荷尔蒙不孕症
  • 闭经
  • 多囊性卵巢症候群
  • 停经后骨质疏鬆症

第9章美洲女性健康市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太女性健康市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东及非洲女性保健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业
    • 併购
    • 合约、合作和伙伴关係
    • 投资、资金筹措
    • 奖项/奖励/扩展

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-434CCDA04E4A

The Global Women's Health Market is forecasted to grow significantly, with a projected USD 43.23 billion in 2023 at a CAGR of 8.91% and expected to reach a staggering USD 78.90 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Women's Health Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Women's Health Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Age, market is studied across 13-17 Years, 18-35 Years, and 36 Years & Above. The 18-35 Years commanded largest market share of 41.01% in 2022, followed by 36 Years & Above.

Based on Distribution Channel, market is studied across Hospital, Online, and Retail. The Retail commanded largest market share of 62.12% in 2022, followed by Hospital.

Based on Application, market is studied across Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome, and Postmenopausal Osteoporosis. The Polycystic Ovary Syndrome commanded largest market share of 23.23% in 2022, followed by Contraceptives.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.34% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Women's Health Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Women's Health Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women's Health Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women's Health Market?

4. What is the competitive strategic window for opportunities in the Global Women's Health Market?

5. What are the technology trends and regulatory frameworks in the Global Women's Health Market?

6. What is the market share of the leading vendors in the Global Women's Health Market?

7. What modes and strategic moves are considered suitable for entering the Global Women's Health Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Women's Health Market, by Age, 2022 vs 2030
  • 4.3. Women's Health Market, by Distribution Channel, 2022 vs 2030
  • 4.4. Women's Health Market, by Application, 2022 vs 2030
  • 4.5. Women's Health Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
      • 5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
      • 5.1.1.3. Inclination of women towards natural and plant based health supplements
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
      • 5.1.3.2. Favorable policies initiated by governments worlwide to improve women's health
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects associated with consumption of drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Women's Health Market, by Age

  • 6.1. Introduction
  • 6.2. 13-17 Years
  • 6.3. 18-35 Years
  • 6.4. 36 Years & Above

7. Women's Health Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Online
  • 7.4. Retail

8. Women's Health Market, by Application

  • 8.1. Introduction
  • 8.2. Contraceptives
  • 8.3. Endometriosis & Uterine Fibroids
  • 8.4. Hormonal Infertility
  • 8.5. Menopause
  • 8.6. Polycystic Ovary Syndrome
  • 8.7. Postmenopausal Osteoporosis

9. Americas Women's Health Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Women's Health Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women's health segment.
      • 12.3.1.2. Unified Women's Healthcare acquires menopause care platform Gennev.
      • 12.3.1.3. Carlyle and PAI on women's healthcare.
      • 12.3.1.4. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Onsite Women's Health and Volpara Health Announce National Partnership.
      • 12.3.2.2. HempStreet announces strategic partnership with Gynica.
    • 12.3.3. Investment & Funding
      • 12.3.3.1. Women's health startup Iron Health launches with $4.5M.
      • 12.3.3.2. Kiran Mazumdar Shaw invests in women's health platform Gytree.com.
      • 12.3.3.3. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
    • 12.3.4. Award, Recognition, & Expansion
      • 12.3.4.1. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2022 VS 2030 (%)
  • FIGURE 5. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 6. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. WOMEN'S HEALTH MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. WOMEN'S HEALTH MARKET DYNAMICS
  • FIGURE 9. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 5. WOMEN'S HEALTH MARKET SIZE, BY 13-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. WOMEN'S HEALTH MARKET SIZE, BY 36 YEARS & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 9. WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOMEN'S HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. WOMEN'S HEALTH MARKET SIZE, BY ENDOMETRIOSIS & UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. WOMEN'S HEALTH MARKET SIZE, BY HORMONAL INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. WOMEN'S HEALTH MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. WOMEN'S HEALTH MARKET SIZE, BY POSTMENOPAUSAL OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 147. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 148. WOMEN'S HEALTH MARKET LICENSE & PRICING